Mycobacterium Leprae Pathogenesis and Immune Response

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson
Download our mobile app to listen on the go
Get App

Questions and Answers

Which of the following mechanisms allows Mycobacterium leprae to evade the host's immune response within macrophages?

  • Triggering apoptosis in infected macrophages, limiting the spread of the bacterium to surrounding tissues.
  • Inhibiting the acidification of the phagosome, preventing the activation of lysosomal enzymes. (correct)
  • Stimulating the production of reactive oxygen species to overwhelm the macrophage's defense mechanisms.
  • Activating the complement pathway to promote opsonization and subsequent clearance by other immune cells.

In lepromatous leprosy, the humoral immune response driven by Th2 cells is considered ineffective against Mycobacterium leprae primarily because:

  • Th2 cytokines suppress the activity of cytotoxic T cells, which are crucial for eliminating intracellular pathogens.
  • The bacteria reside within cells, making them inaccessible to circulating antibodies. (correct)
  • The excessive antibody production leads to immune complex formation, causing widespread inflammation and tissue damage.
  • Antibodies produced by B cells are unable to penetrate the thick, waxy cell wall of _M. leprae_.

A patient presents with hypopigmented skin patches and localized loss of sensation. A skin biopsy reveals granulomas but very few acid-fast bacilli. Which of the following immunological profiles is most consistent with these findings?

  • Increased regulatory T cell (Treg) activity, suppressing both Th1 and Th2 responses and promoting bacterial persistence.
  • Predominance of Th2 cytokines (IL-4, IL-5, IL-10) and high antibody titers against _M. leprae_.
  • Dominant Th1 response with elevated levels of IL-2 and IFN-γ, leading to macrophage activation and granuloma formation. (correct)
  • Suppressed cell-mediated immunity with impaired macrophage activation and reduced IFN-γ production.

Why is multidrug therapy (MDT) essential in the treatment of leprosy?

<p>To prevent the emergence of drug-resistant strains of <em>M. leprae</em>. (A)</p> Signup and view all the answers

The predilection of Mycobacterium leprae for infecting peripheral nerves is directly linked to its affinity for:

<p>Laminin-2 expressed on Schwann cells, a type of glial cell that supports peripheral neurons. (D)</p> Signup and view all the answers

A researcher aims to study the growth characteristics of Mycobacterium leprae in vitro. Which of the following approaches is most likely to yield successful cultivation of the bacteria?

<p>Inoculating the bacteria into tissue culture cells at 30°C in a microaerophilic environment. (B)</p> Signup and view all the answers

A patient with lepromatous leprosy exhibits facial nerve paralysis, leading to lagophthalmos. What is the primary concern associated with this condition?

<p>Corneal damage and ulceration due to exposure and dryness. (B)</p> Signup and view all the answers

The unique staining property of Mycobacterium leprae as an acid-fast bacillus (AFB) is attributed to which of the following cell wall components?

<p>Mycolic acid, which forms a waxy, hydrophobic layer that resists decolorization by acids. (A)</p> Signup and view all the answers

In the context of leprosy diagnosis, a positive lepromin skin test typically indicates:

<p>A strong cell-mediated immune response against <em>M. leprae</em>, characteristic of tuberculoid leprosy. (B)</p> Signup and view all the answers

What is the underlying pathological mechanism that leads to the collapse of the nose observed in some cases of lepromatous leprosy?

<p>Direct invasion and destruction of the nasal cartilage by <em>M. leprae</em>. (B)</p> Signup and view all the answers

Flashcards

Mycobacterium Leprae

Rod-shaped bacterium that causes leprosy (Hansen’s disease); an obligate intracellular organism that grows slowly at cool temperatures.

Pathogenesis of M. Leprae

M. leprae enters through broken skin/lungs, targeting cooler areas like skin, peripheral nerves, and upper respiratory tract mucosa; infects Schwann cells, causing demyelination and nerve injury.

Immune Response to Leprosy

Involves a cell-mediated response via Th1 and Th2 cells; Th1 cells activate cytotoxic T cells and macrophages, while Th2 cells promote B-cell activation and antibody production.

Risk Factors for Leprosy

Close contact with infected individuals/armadillos, older age, and immunosuppressive conditions.

Signup and view all the flashcards

Clinical Features: Lepromatous

Numerous raised skin lesions, diminished sensation, paresthesias, facial changes (lion-like), extremity destruction, ocular involvement, and facial nerve paralysis.

Signup and view all the flashcards

Skin Biopsy for Leprosy

Foam cells with many bacilli in active lesions suggest lepromatous; few acid-fast bacilli and granulomas suggest tuberculoid.

Signup and view all the flashcards

PCR for Leprosy

Detects M. leprae DNA to confirm the diagnosis.

Signup and view all the flashcards

Lepromin Skin Test

(Positive = induration) suggests tuberculoid; negative suggests lepromatous.

Signup and view all the flashcards

Treatment of Leprosy

Lepromatous: dapsone, rifampin, and clofazimine for 12 months; Tuberculoid: dapsone and rifampin for 6 months.

Signup and view all the flashcards

Clinical Features: Tuberculoid

Hypopigmented skin patches, mild nerve involvement, weakness in hands, and foot drop; induces a Th1 cell response; limited lesions and asymmetric nerve involvement; low bacteria numbers.

Signup and view all the flashcards

Study Notes

  • Mycobacterium leprae is a rod-shaped, obligate intracellular bacterium, meaning it can only survive inside cells.
  • It causes leprosy, also known as Hansen’s disease.
  • Optimal growth occurs at cool temperatures (27–33°C), with slow proliferation; it is also an obligate aerobe.

Pathogenesis of Mycobacterium Leprae

  • M. leprae enters through broken skin or the lungs, targeting cooler body areas like skin, peripheral nerves, and upper respiratory tract mucosa.
  • It infects Schwann cells of peripheral nerves, which are responsible for myelin sheath formation around axons.
  • M. leprae binds to laminin-2 on Schwann cells through phenolic glycolipid 1 (PGL-1), leading to demyelination and nerve injury.
  • It evades destruction inside macrophages by inhibiting phagolysosomal fusion, allowing intracellular replication.

Immune Response

  • Leprosy initiates a cell-mediated immune response via T-helper cells (Th1 and Th2).
  • Th1 cells produce interleukin-2 (IL-2) and interferon gamma (IFN-γ), activating cytotoxic T cells, macrophages, and natural killer cells.
  • Th2 cells release IL-4, IL-5, and IL-10, stimulating B-cell activation and antibody production.

Risk Factors

  • Close contact with infected individuals or armadillos, which serve as animal reservoirs of the bacteria, increases risk.
  • Older age and immunosuppressive conditions like diabetes, malignancy, or HIV infection are also risk factors.

Clinical Features of Leprosy

  • Lepromatous form presents as numerous, raised, poorly demarcated skin lesions, often on the extremities.
  • Symptoms of the Lepromatous form include diminished or absent sensation in affected areas and paresthesias (tingling or numbness) in hands or feet.
  • Facial changes such as lion-like features, skin thickening, and eyebrow/eyelash loss is a sign of the Lepromatous form.
  • In the Lepromatous form, extremity destruction includes collapse of the nose and loss of fingers/toes and ocular involvement such as uveitis.
  • Facial nerve paralysis in the Lepromatous form leads to lagophthalmos (inability to close eyelids), potentially causing corneal ulcers.
  • Lepromatous form induces a Th2 cell response resulting in a humoral (antibody-based) immune response which is ineffective against intracellular pathogens.
  • Extensive skin involvement and symmetric nerve damage is due to the Lepromatous form, also known as multibacillary leprosy, which entails large bacterial numbers in lesions.
  • Tuberculoid form presents as hypopigmented or reddish, well-demarcated skin patches.
  • Symptoms of the Tuberculoid form, include mild nerve involvement, large peripheral nerve tenderness, hand weakness (claw fingers), and foot drop.
  • Tuberculoid leprosy induces a Th1 cell response and a cell-mediated immune response.
  • Tuberculoid form results in limited skin lesions and asymmetric nerve involvement, also called paucibacillary leprosy because of the low numbers of bacteria in lesions.

Diagnosis of Leprosy

  • Diagnosis involves examining active skin lesion biopsies for acid-fast bacilli.
  • Lepromatous form shows foam cells (lipid-laden macrophages) with many bacilli.
  • Tuberculoid form displays few acid-fast bacilli and granulomas (immune cell collections).
  • Polymerase chain reaction (PCR) detects M. leprae DNA.
  • A positive Lepromin skin test (induration after 48 hours) suggests tuberculoid leprosy, a negative result suggests lepromatous leprosy.
  • M. leprae is an acid-fast bacillus (AFB) due to its high mycolic acid content, which makes its cell wall waxy.
  • M. leprae is hydrophobic and impermeable to routine stains like Gram stain, thus special stains like Ziehl-Neelsen are needed for visualization.
  • The bacterium cannot be cultivated in vitro and must be inoculated in nine-banded armadillos due to their lower body temperature.

Treatment

  • Multidrug therapy is crucial to prevent resistance.
  • Lepromatous form is treated with dapsone, rifampin, and clofazimine for 12 months.
  • Tuberculoid form is treated with dapsone and rifampin for 6 months.

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

More Like This

Mycobacterium Leprae (Leprosy) Quiz
12 questions
Mycobacterium leprae and Leprosy
24 questions
Leprosy (Hansen's Disease) Overview
25 questions
Use Quizgecko on...
Browser
Browser